Fastforward Innovations Share Discussion Threads

[thelogman] 09/8/2018 18:37

Evening monkeymonkey, was not a dig at you was just stating all out there to see.We will be fine here.

[monkeymonkey] 09/8/2018 09:25

well nothing happening on here and nothing happening with FFWD, as they said all action could or should be known by end of september, so for now were in no man's land, enjoy the wait lol,

[monkeymonkey] 09/8/2018 08:06

morning logman ur right nothing new it was on the crypto site just thought they had put the article together quite well that's all, FFWD needs airtime so every bit helps, my only worry now is hows the FCT funding going, i hope FFWD early investment wasn't just to keep FCT going ? but a stroke of genius

[thelogman] 08/8/2018 22:00

Good night,can not be bothered go lse and listen to rubbish.Ffwd will do us all good no probs.

[thelogman] 08/8/2018 21:58

They were not big buys as richthenewbie says, absolute obvious to anyone who as aim knowledge.

[hazl] 08/8/2018 21:58

It is a site that is quite interesting.
Sure the investment is already known....what's the problem?

[hazl] 08/8/2018 15:08

good find monkey...

[monkeymonkey] 08/8/2018 08:30

Blockchain record-tracking company Factom is taking a $6 million investment from an investment firm that’s traded on a submarket of the London Stock Exchange (LSE), reports Xconomy (FinTech Fututes’ sister publication).

FastForward Innovations has created what’s known as a Simple Agreement for Future Equity (sometimes called a SAFE note) to invest the $6 million in Factom, which was founded in Austin, Texas in 2015.

Under the terms of the deal, FastForward’s investment gets converted into shares of Factom’s Series B round of Funding at a 25% discount. Factom has proposed the round, but hasn’t announced the terms of yet, according to FastForward.

Additionally, FastForward has the option to invest as much as $9 million more on the same terms by 30 September, according to a release filed with the LSE.

FastForward invests in early stage businesses and trades on the LSE’s Alternative Investment Market (AIM), which is focused on smaller growing companies, according to the LSE.

Factom plans to use the funds to build out and scale its Software-as-a-Service platform. The company also plans to expand its roadmap for products, expand its sales and marketing teams, and invest in other operations.

Factom also planned to use the funding to expand its patent portfolio to more than 20 from 14 – which it has already started doing. The company filed a patent related to verifying documents on a blockchain, around the same time that other corporate giants like Walmart and IBM filed other blockchain-related patents.

Factom uses blockchain technology to secure and verify data such as public records and business documents, giving large and small businesses and government organisations access to a system that maintains permanent, time-stamped records and data.

The company is still generating its full revenue model, but says it has worked with numerous firms, including those in the banking, financial services and insurance industries, as well as government entities, such as the US Department of Homeland Security.

FastForward said Factom had gross assets of $1.4 million as of 30 March, and reported a loss of $4.7 million in 2017.

Factom closed its Series A round of funding in 2017 at about $8 million. It was led by Tim Draper, the noted venture capitalist who runs investment firm Draper Associates. Peeli Ventures, Harvest Equity, and a group of local Austin investors also participated.

Other than Factom, FastForward lists seven investments on its website, including a 3D gaming company called Leap Gaming and a cancer immunotherapy company called Intensity Therapeutics. The $6 million investment in Factom is FastForward’s largest investment to date, the company says. In fact, FastForward said it borrowed $800,000 from its CEO, Lorne Abony, in order to secure the deal with Factom.

FastForward is headquartered in the Bailiwick of Guernsey, a crown dependency of the UK. It was previously known as Kuala Innovations.

In 2006, Abony sold a company he co-founded called Fun Technologies, which was traded on the Toronto Stock Exchange, for CA$484 million ($415 million).

[thelogman] 06/8/2018 20:18

Listen to loggy, get your money in here, big gains to be had, loggy is a cash machine.21 days you are in big profits, loggy has been emailed.Make of it what you will.Told peeps it was gonna spike last time, i,m telling you now this is gonna spike, you rather believe or you don,t.

[kristini2] 06/8/2018 20:12

Jim's kept DBC alive, you think he cares about small investors? -he's a ruthless businessman and very successful, you don't make Jim's money by being a socialist thinking chap, sorry but i fear we'll be stuffed, time will tell if the business works

[adred] 06/8/2018 19:44

kristini2,I am a direct investor in DBC too :-(

Jim Mellon was encouraging people to invest in DBC at the Master Investor Shows, I get his loans kept the business afloat but he needs to play fair by small shareholders.

I think its a question of trust, will Jim Mellon do the right thing?

Lets be honest most investors have invested because of Jim Mellon pumping it and his expertise in this field.

It's not been a good investment lets hope it come right soon.

[kristini2] 06/8/2018 17:12

problem with DBC is that Jim has a convertible loan note to DBC which kept the business afloat, when this converts to equity existing shareholders may get diluted out .....

i'm a direct investor in DBC as well as in ffwd

[adred] 06/8/2018 12:37

Update on DBC ;

23 July 2018

The team at PulseFlow Technologies continue to make a positive impact in the wound healing arena, connecting global medical Distributors with exceptional opportunities.

In-house developments earlier this year saw the appointment of Dan Blackman as COO. A qualified experienced Podiatrist and clinical lead specialist makes Dan ideally placed to oversee operations for the advancement of PFDF.

Alongside developing PFDF - our award-winning medical device for assisting Diabetic Foot Ulcer recovery, the broader potential of offering this device to Vascular Surgical teams is being developed for patients recovering from post-operative revascularisation surgery to ensure that presenting poor circulatory systems don’t delay healing and create poor patient outcomes. The larger category available to us increases clinical appeal without diluting our core product offer is a significant re focus and positive development.
Dedicated specialists, partners and associates look to Stella Withy, PFT UK General Manager to answer commercial matters.

The next half of 2018 will see us focus on establishing strong relationships in manufacturing and distribution channels. Interested in onboarding this innovative Class IIa medical device solution for lower limb issues in your portfolio?

[neutronium] 06/8/2018 12:10

Nice example Jonesy, thank you. I suspect that due to dubious motives some individuals will ignore the obvious and resort to scare mongering. That said, if you are swayed in your investment decisions by BB comments you probably shouldn't be investing in the first place!! Anyway, back to lurking :)

[jonesyboy 27] 06/8/2018 09:24

It’s a simple as this...
FCT is to Factom as Nectar ponts are to Sainsburys...loosely linked but zero to do with factom.inc.
Factom.org = FCT. WE ARE INVESTED IN FACTOM.INC.
How difficult is it to understand?

[hazl] 06/8/2018 09:15

That is so common neutronium....I have despaired at the lack of research and interest in APPS for example.
They got finance from buyers at 70p a share...yet look at it now all because of
a W i n n ifrith article.

However great to see renewed interest here.

[neutronium] 06/8/2018 08:56

Sigh - for the last time trendspotting - they did NOT invest in the coin, please do some research other than merely looking at the name

[trendspotting] 06/8/2018 07:53

Value of this coin has been destroyed - hxxps://coinmarketcap.com/currencies/factom/

Did the BOD get it right investing in FCT here?

[kristini2] 05/8/2018 19:08

Might Lorne be holding back, possibly to make personal investments directly to factom and others ?

There can be conflicts of interest along the way when following Mellon and Co

Consider Diabetic Boot- mellon has lent that Company a convertible note basis to keep it afloat, On conversion of that note to equity is it possible that all existing shareholders effectively get diluted out?

Anyone have any knowledge or thoughts in convertible loans ?

[brave dave] 03/8/2018 23:52

Must admit slightly disappointed. But then again long term still have very high hopes.
I think people have bought in and out of ffwd over the last year after foolishly listening to the ridiculous rampers, saying that this would multibag over and over in no time..This is one for the future, a few years down the road. and they sell out after realising that this is not a share that will multibag in a matter of weeks. Lorne made millions from his own stake in Aphria, he also sold over £2million pounds worth of his ffwd stock to his buddy for 17p a share just a couple of months back, and all he buys back in is £400k. Dissapointed but will continue to hold for the long term, lets hope we get a raise in NAV from Factom B.

[888icb] 03/8/2018 19:11

However the very large amount of the placing taken by 2 Directors Lorne £487000 and Jim Mellon £761000 indicate that this is an absolute certainty to be worth a lot more than 13p. Fireworks in the not to distant future. These guys invest for big returns.

[888icb] 03/8/2018 19:03

It is poor attention to detail that the second RNS says “there will be not be an open offer” Which is it?

[biggest bill] 03/8/2018 13:38

The second rns is very good news. This means that anybody wanting shares at around 13p will have to buy in the market.